J22352, a PROTAC-Like and Highly Selective HDAC6 Inhibitor, Enhances Antitumor Immunity in Glioblastoma
Glioblastomas (also called GBM) are malignant Grade IV tumors, where a large portion of tumor cells are reproducing and dividing at any given time. They are nourished by an ample and…
